Allarity Therapeutics, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Allarity Therapeutics, Inc. (ALLR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $180.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2023-08-14
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $180.00K.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-03-31 was -$121.00K, a 111.36% decline year-over-year.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2022-09-30 was $406.00K, a 29.64% decline year-over-year.
- Allarity Therapeutics, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2022-06-30 was -$59.00K, a 113.63% decline year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month |
|---|---|---|---|
| 2023-06-30 | $180.00K 10-Q · filed 2023-08-14 | $59.00K derived: sum of 2 quarters · filed 2023-08-14 | |
| 2023-03-31 | -$121.00K 10-Q · filed 2023-08-14 | ||
| 2022-09-30 | $406.00K 10-Q · filed 2022-11-14 | $347.00K derived: sum of 2 quarters · filed 2023-08-14 | $1.41M derived: sum of 3 quarters · filed 2023-08-14 |
| 2022-06-30 | -$59.00K 10-Q · filed 2023-08-14 | $1.01M derived: sum of 2 quarters · filed 2023-08-14 | |
| 2022-03-31 | $1.06M 10-Q · filed 2023-08-14 | ||
| 2021-09-30 | $577.00K 10-Q · filed 2022-11-14 | $1.01M derived: sum of 2 quarters · filed 2022-11-14 | $1.21M derived: sum of 3 quarters · filed 2022-11-14 |
| 2021-06-30 | $433.00K 10-Q · filed 2022-11-14 | $628.00K derived: sum of 2 quarters · filed 2022-11-14 | |
| 2021-03-31 | $195.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |